Cryptococcal Virulence in Humans: Learning From Translational Studies With Clinical Isolates.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Pathogen-Host Interactions

Background:

• Cryptococcosis, caused by *Cryptococcus* spp., is a life-threatening invasive fungal infection with high mortality rates (20-70%).
• Current prevention (no vaccines) and treatment options (limited antifungals) are insufficient, necessitating novel therapeutic approaches.
• Challenges in cryptococcosis research include imperfect experimental models and ethical limitations of human studies.

Purpose of the Study:

• To review studies investigating cryptococcosis pathophysiology by correlating laboratory findings of fungal isolates with patient data.
• To highlight the clinical impact of specific fungal attributes in *Cryptococcus* species.
• To identify strategies for improving patient outcomes in cryptococcosis.

Main Methods:

• Collection and laboratory analysis of cryptococcal clinical isolates and associated patient data.
• Assessment of fungal virulence factors, host-pathogen interactions, and molecular markers in vitro.
• Correlation of laboratory data with clinical outcomes to understand the role of fungal attributes in human disease.

Main Results:

• Fungal isolates evading macrophage responses, secreting more laccase, melanizing faster, and possessing larger capsules in cerebrospinal fluid are associated with poorer patient outcomes.
• Distinct cryptococcal clades exhibit varying virulence, impacting clinical presentation and prognosis.
• Despite limitations like small isolate numbers and retrospective data, this integrated approach yields crucial insights.

Conclusions:

• Correlating fungal traits with clinical data is a powerful strategy for understanding cryptococcosis pathogenesis.
• Identifying specific virulence factors offers targets for developing new antifungal therapies.
• International collaboration is essential to expand knowledge and improve cryptococcosis patient care.